Myelo Therapeutics GMBH
- UEI
- G1LNCHNLYXF6
- CAGE
- DP990
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- International Organization
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Website
- myelotherapeutics.com
- Founded
- 2013
- Employees
- 1-10
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- SIC code
- 38 Instruments & Related Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Development of MYELO001 as an orally applied medical countermeasure for the treatment of hematopoietic acute radiation… | National Institute of Allergy and Infectious Diseases | $6,728,096 |
Quick answers
What is Myelo Therapeutics GMBH's UEI?
Myelo Therapeutics GMBH's Unique Entity ID (UEI) in SAM.gov is G1LNCHNLYXF6.
What is Myelo Therapeutics GMBH's CAGE code?
Myelo Therapeutics GMBH's CAGE code is DP990.
What is Myelo Therapeutics GMBH's primary NAICS code?
Myelo Therapeutics GMBH's primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).
Is Myelo Therapeutics GMBH registered in SAM.gov?
Myelo Therapeutics GMBH's SAM.gov registration expired on January 14, 2026.
What is Myelo Therapeutics GMBH's most recent federal award?
Myelo Therapeutics GMBH's most recent federal contract award is Development of MYELO001 as an orally applied medical countermeasure for the treatment of hematopoietic acute radiation… (75N93020C00005), from National Institute of Allergy and Infectious Diseases, on May 1, 2020.
On GovTribe
See Myelo Therapeutics GMBH's full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors